Lumen Bioscience Announces Appointment of Dr. Mark Litton to Board of Directors

Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced the appointment of Mark Litton, PhD, MBA, Chief Operating Officer of Athira Pharma (NASDAQ: ATHA), to the company's Board of Directors...
Login to comment.